Cancer Targeted Technology
Manufacturing · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
14241 NE Woodinville Duvall Rd PMB 143, ...Phone Number
(509) 592-7034Revenue
$5.8 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Cancer Targeted Technology
Cancer Targeted Technology specializes in the design and patenting of small molecule drugs aimed at diagnosing and treating cancer, particularly prostate cancer. Their product offerings include CTT1057, a PET imaging agent, CTT1403, a radiotherapeutic, and CTT2274, a chemotherapeutic. The company focuses on innovative solutions that combine diagnostic imaging with therapeutic properties. Their intended clients include healthcare providers and researchers in the oncology field.Explore more
Cancer Targeted Technology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cancer Targeted Technology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Cancer Targeted Technology, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Cancer Targeted Technology
Website visits: Recent activity has been detected on your website
Check if Cancer Targeted Technology has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Cancer Targeted Technology recently announced quarterly report
Click to see if Cancer Targeted Technology had a recent Job posting/layoffs
Product Launch: Get notified when Cancer Targeted Technology launches new products
Check out if Cancer Targeted Technology is spiking on competitors!
Funding: Get notified immidiatlly once Cancer Targeted Technology has new funding data
Recommended Actions
Reach out to Masked Content who joined Cancer Targeted Technology as Masked Content
Find 2 more new buyers
Compare Similar Companies to Cancer Targeted Technology
Compare insights from companies similar to Cancer Targeted Technology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$123.9M
51-200
Public
$547.1M
1994
JB
Jennifer BuellPresident and CEO of MiNK Therapeutics, Chairman, Executive Council At Agenus
Company Profile Activity
Activity Insights
Cancer Targeted Technology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cancer Targeted Technology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cancer Targeted Technology.
Cancer Targeted Technology Tech Stack
A closer look at the technologies used by Cancer Targeted Technology
Cancer Targeted Technology News & Media
Cancer Targeted Technology Receives Milestone Payment for Development of Diagnostic PET Imaging Agent for Prostate Cancer
SEATTLE--(BUSINESS WIRE)--Cancer Targeted Technology receives milestone paymentNIH grants $1.44M to Cancer Targeted Technology to Support the Ongoing Prostate Cancer Clinical Trial of a Promising New Radiotherapeutic, CTT1403
SEATTLE--(BUSINESS WIRE)--Cancer Targeted Technology receives $1.44M in year 2 of SBIR Phase IIB grant to fund clinical trial of new PSMA-targeted therapeutic agent, CTT1403.Cancer Targeted Technology Commences Phase I Clinical Trial in Prostate Cancer Patients with an Innovative Radiotherapy, CTT1403, and Receives a $3.2M NIH Grant to Fund the Trial
SEATTLE--(BUSINESS WIRE)--Cancer Targeted Technology commences a Phase I prostate cancer clinical trial using the radiotherapy CTT1403, and is awarded a $3.2M SBIR grant.Cancer Targeted Technology Files Investigational New Drug Application for CTT1403, a Novel Radiotherapeutic Drug for Prostate Cancer
SEATTLE--(BUSINESS WIRE)--Cancer Targeted Technology files an IND with the FDA to advance a novel PSMA-targeted drug, CTT1403, to clinical trials for advanced prostate cancer.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cancer Targeted Technology
Sign Up For FreeTo access detailed company insights
Cancer Targeted Technology specializes in the design and patenting of small molecule drugs aimed at diagnosing and treating cancer, particularly prostate cancer. Their product offerings include CTT1057, a PET imaging agent, CTT1403, a radiotherapeutic, and CTT2274, a chemotherapeutic. The company focuses on innovative solutions that combine diagnos... Read More
